NIBRT Appoints Dr Fiona Killard-Lynch as Director of Research and Innovation
The National Institute for Bioprocessing Research and Training (NIBRT) is pleased to announce the appointment of Dr Fiona Killard-Lynch as the Director of Research and Innovation.
Before assuming this important new role at NIBRT, Dr Killard-Lynch served as the Head of Strategic Research Development and Director of the Office of the Dean of Research at Trinity College Dublin (Trinity). In this capacity, she led the development and implementation of Trinity’s research strategies and policies and, with her team, contributed strongly to improvements in the University’s world ranking performance.
Fiona has over two decades of experience in the higher education sector, across France, New Zealand, the United Kingdom, and Ireland. Prior to joining Trinity, Fiona worked at the University of Bristol, where she successfully established and managed the Bristol Doctoral College (BDC) and was an invited member of the UK Council for Graduate Education. Her expertise in securing European Union funding, her role as a Framework expert across multiple programmes and her comprehensive understanding of the higher education landscape have established her as a respected leader in the field.
Dr Killard-Lynch expressed her enthusiasm for the new role, stating, “It’s an honour to join such a prestigious institution and become part of the NIBRT team. I am excited about the opportunity to collaborate with some of the brightest minds in biopharma research, and together, to push the boundaries of knowledge and create a meaningful impact on society. I am committed to ensuring that NIBRT continues to be recognised the best institution in which to conduct biopharma research by supporting the most talented researchers, encouraging innovation, interdisciplinary collaboration, and the pursuit of excellence.”
As Director of Research and Innovation, Dr Killard-Lynch will play a pivotal role in shaping the future direction of NIBRT and advancing our mission of driving innovation and impactful biopharma manufacturing research.
NIBRT’s CEO, Darrin Morrissey, commented: “I am delighted to welcome Dr. Fiona Killard-Lynch to NIBRT’s dynamic team. Her extensive experience and innovative mindset make her the ideal leader to guide our research and innovation initiatives to new heights.”
NIBRT’s Board of Directors Chair, Julie O’Neill, added, “With Dr Killard-Lynch at the helm of our research and innovation endeavors, we look forward to elevating NIBRT’s global standing and enhancing our collaboration with industry leaders and research institutes.”